{"product_id":"test-urinaire-drugdiag®-6t2-nouvelles-drogues-de-synthese","title":"Test Urinario 6 Droghe Drugdiag® 6T2 - Nuove Droghe di sintesi","description":"\u003cstyle\u003e\n\/* =========================================================\n   AMA Prévention — B-SAFE\n   Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n   Sans JS — prêt Shopify\n   ========================================================= *\/\n\n.ama-bsafe-2026 {\n  --ama-blue: #004C96;\n  --ama-blue-deep: #003B78;\n  --ama-blue-night: #00325f;\n  --ama-orange: #FE4B09;\n  --ama-text: #004C96;\n  --ama-muted: #667085;\n  --ama-border: #dbe6f2;\n  --ama-soft: #f6f9fd;\n  --ama-white: #ffffff;\n\n  width: 100%;\n  max-width: 1180px;\n  margin: 0 auto;\n  padding: 0;\n  font-family: inherit;\n  color: var(--ama-text);\n  background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n  box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n  min-width: 0;\n}\n\n.ama-bsafe-panel {\n  width: 100%;\n  position: relative;\n  overflow: hidden;\n  isolation: isolate;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 28px;\n  background:\n    radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n    radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n    linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n  box-shadow:\n    0 22px 55px rgba(0, 76, 150, 0.10),\n    inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n  width: 100%;\n  padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n  margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  margin-bottom: 14px;\n  padding: 7px 12px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 12px;\n  font-weight: 900;\n  letter-spacing: 0.04em;\n  text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n  margin: 0 0 16px;\n  color: var(--ama-blue);\n  font-size: clamp(30px, 4vw, 46px);\n  line-height: 1.08;\n  font-weight: 900;\n  letter-spacing: -0.045em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n  margin: 0 0 16px;\n  color: var(--ama-text);\n  font-size: clamp(16px, 1.4vw, 18px);\n  line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n  color: var(--ama-blue);\n  font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n  display: flex;\n  flex-wrap: wrap;\n  gap: 10px;\n  margin-top: 26px;\n  padding: 14px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: rgba(255, 255, 255, 0.72);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n  display: inline-flex;\n  align-items: center;\n  gap: 8px;\n  flex: 1 1 230px;\n  padding: 10px 12px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  color: var(--ama-blue);\n  font-size: 14px;\n  font-weight: 850;\n  line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n  content: \"\";\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n  flex-shrink: 0;\n}\n\n\/* =========================================================\n   Accordéon principal\n   Fermé : bleu nuit\n   Ouvert : clair + contenu dans le même bloc\n   ========================================================= *\/\n\n.ama-bsafe-accordion {\n  width: 100%;\n  max-width: 920px;\n  margin: 0 auto;\n  display: grid;\n  gap: 12px;\n}\n\n.ama-bsafe-item {\n  border-radius: 24px;\n  overflow: hidden;\n  background:\n    linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n  border: 1px solid rgba(0, 76, 150, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.22),\n    inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n    0 16px 36px rgba(0, 76, 150, 0.17);\n  transition:\n    background 220ms ease,\n    box-shadow 220ms ease,\n    border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n  background:\n    radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n    linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n  border-color: rgba(0, 76, 150, 0.14);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.98),\n    0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n  position: relative;\n  min-height: 66px;\n  padding: 14px 58px 14px 18px;\n  display: flex;\n  align-items: center;\n  cursor: pointer;\n  list-style: none;\n  user-select: none;\n  -webkit-tap-highlight-color: transparent;\n  color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-item[open] summary {\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n  border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 16px;\n  top: 50%;\n  width: 36px;\n  height: 36px;\n  transform: translateY(-50%);\n  border-radius: 999px;\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  color: #ffffff;\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n  border: 1px solid rgba(255, 255, 255, 0.26);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.30),\n    0 10px 22px rgba(0, 0, 0, 0.14);\n  font-size: 22px;\n  font-weight: 760;\n  line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n  content: \"−\";\n  color: var(--ama-blue);\n  background:\n    linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n  border-color: rgba(0, 76, 150, 0.10);\n  box-shadow:\n    inset 0 1px 0 rgba(255, 255, 255, 0.96),\n    0 8px 18px rgba(0, 76, 150, 0.10);\n  font-size: 24px;\n  font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-item:not([open]):hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.26),\n      inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n      0 20px 44px rgba(0, 76, 150, 0.22);\n  }\n\n  .ama-bsafe-item[open]:hover {\n    box-shadow:\n      inset 0 1px 0 rgba(255, 255, 255, 0.98),\n      0 18px 42px rgba(0, 76, 150, 0.13);\n  }\n}\n\n.ama-bsafe-acc-title {\n  display: block;\n  font-size: 16px;\n  line-height: 1.18;\n  font-weight: 800;\n  letter-spacing: -0.018em;\n  color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n  display: block;\n  margin-top: 3px;\n  font-size: 13px;\n  line-height: 1.24;\n  font-weight: 650;\n  letter-spacing: -0.01em;\n  color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n  color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n  padding: clamp(20px, 4vw, 34px);\n  background: transparent;\n  animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n  from {\n    opacity: 0;\n    transform: translateY(5px);\n  }\n\n  to {\n    opacity: 1;\n    transform: translateY(0);\n  }\n}\n\n\/* =========================================================\n   Contenu\n   ========================================================= *\/\n\n.ama-bsafe-content h2 {\n  margin: 0 0 18px;\n  color: var(--ama-blue);\n  font-size: clamp(24px, 3vw, 36px);\n  line-height: 1.10;\n  font-weight: 900;\n  letter-spacing: -0.04em;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n  content: \"\";\n  display: block;\n  width: 78px;\n  height: 4px;\n  margin-top: 14px;\n  border-radius: 999px;\n  background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n  margin: 0 0 10px;\n  color: var(--ama-blue);\n  font-size: clamp(18px, 1.7vw, 23px);\n  line-height: 1.18;\n  font-weight: 900;\n  letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n  margin: 0 0 18px;\n  color: var(--ama-text);\n  font-size: 16px;\n  line-height: 1.72;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n  display: grid;\n  grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n  gap: 18px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-card {\n  position: relative;\n  min-height: 150px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 22px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow-wrap: break-word;\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n  margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n  .ama-bsafe-card:hover,\n  .ama-bsafe-substance-row:hover {\n    transform: translateY(-2px);\n    border-color: rgba(254, 75, 9, 0.32);\n    background: #ffffff;\n    box-shadow:\n      0 16px 34px rgba(0, 76, 150, 0.10),\n      inset 0 1px 0 rgba(255, 255, 255, 0.95);\n  }\n}\n\n.ama-bsafe-substance-list {\n  display: grid;\n  gap: 12px;\n  margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n  width: 100%;\n  display: flex;\n  align-items: center;\n  flex-wrap: wrap;\n  gap: 12px 18px;\n  padding: 16px 18px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 20px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  transition:\n    transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n    border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 130px;\n  width: 130px;\n  min-width: 130px;\n  max-width: 130px;\n  min-height: 38px;\n  padding: 7px 14px;\n  border-radius: 999px;\n  background: rgba(0, 76, 150, 0.08);\n  color: var(--ama-blue);\n  font-size: 15px;\n  font-weight: 950;\n  letter-spacing: -0.01em;\n  text-align: center;\n}\n\n.ama-bsafe-substance-main {\n  flex: 1 1 420px;\n  min-width: min(100%, 320px);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  flex: 0 0 auto;\n  margin-left: auto;\n  min-height: 34px;\n  padding: 6px 12px;\n  border-radius: 999px;\n  background: rgba(254, 75, 9, 0.08);\n  color: var(--ama-orange);\n  font-size: 13px;\n  font-weight: 900;\n  white-space: nowrap;\n}\n\n.ama-bsafe-list {\n  list-style: none;\n  padding: 0;\n  margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n  position: relative;\n  padding: 15px 18px 15px 44px;\n  margin-bottom: 10px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.84);\n  box-shadow:\n    0 6px 18px rgba(0, 76, 150, 0.035),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  color: var(--ama-text);\n  font-size: 15px;\n  line-height: 1.62;\n  overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n  content: \"\";\n  position: absolute;\n  left: 18px;\n  top: 22px;\n  width: 8px;\n  height: 8px;\n  border-radius: 50%;\n  background: var(--ama-orange);\n  box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n  margin: 22px 0;\n  padding: 18px 20px;\n  border: 1px solid rgba(0, 76, 150, 0.10);\n  border-radius: 18px;\n  background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  color: var(--ama-muted);\n  font-size: 14px;\n  line-height: 1.62;\n  font-style: italic;\n  box-shadow:\n    0 8px 20px rgba(0, 76, 150, 0.04),\n    inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n  margin: 28px 0;\n  padding: 24px;\n  border-radius: 22px;\n  background:\n    radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n    linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  box-shadow:\n    0 16px 34px rgba(254, 75, 9, 0.22),\n    inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n  color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n  margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n  margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n  display: grid;\n  gap: 12px;\n  margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 18px;\n  background: rgba(255, 255, 255, 0.86);\n  box-shadow:\n    0 8px 24px rgba(0, 76, 150, 0.045),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n  overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n  cursor: pointer;\n  padding: 18px 50px 18px 18px;\n  color: var(--ama-blue);\n  font-weight: 900;\n  line-height: 1.35;\n  list-style: none;\n  position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n  display: none;\n}\n\n.ama-bsafe-faq summary::after {\n  content: \"+\";\n  position: absolute;\n  right: 18px;\n  top: 50%;\n  transform: translateY(-50%);\n  color: var(--ama-orange);\n  font-size: 24px;\n  line-height: 1;\n  font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n  content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n  padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n  margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n  margin-top: 30px;\n  padding: 24px;\n  border: 1px solid rgba(219, 230, 242, 0.95);\n  border-radius: 24px;\n  background:\n    radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n    linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n  box-shadow:\n    0 14px 34px rgba(0, 76, 150, 0.08),\n    inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n  margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n  display: inline-flex;\n  align-items: center;\n  justify-content: center;\n  min-height: 46px;\n  padding: 12px 22px;\n  border-radius: 999px;\n  background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n  color: #ffffff !important;\n  font-weight: 900;\n  text-decoration: none;\n  box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n  margin-top: 30px;\n  padding-top: 22px;\n  border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n  margin: 0;\n  color: var(--ama-muted);\n  font-size: 13px;\n  line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n  max-width: 1180px;\n  margin: 32px auto 0;\n  padding: 24px;\n  border: 1px solid rgba(0, 76, 150, 0.18);\n  border-radius: 22px;\n  background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n  box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n  color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n  margin: 0 0 8px;\n  font-size: 13px;\n  letter-spacing: 0.08em;\n  text-transform: uppercase;\n  font-weight: 900;\n  color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n  margin: 0 0 12px;\n  color: #004c96;\n  font-size: clamp(22px, 2.4vw, 30px);\n  line-height: 1.15;\n  font-weight: 900;\n  letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n  margin: 0 0 10px;\n  line-height: 1.65;\n  color: #184b78;\n  font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n  margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n  .ama-bsafe-grid {\n    grid-template-columns: repeat(2, minmax(0, 1fr));\n  }\n\n  .ama-bsafe-substance-row {\n    display: grid;\n    grid-template-columns: 130px minmax(0, 1fr);\n    align-items: start;\n    gap: 10px 14px;\n  }\n\n  .ama-bsafe-substance-code {\n    grid-column: 1;\n    grid-row: 1;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 2;\n    grid-row: 1;\n    justify-self: start;\n    margin-left: 0;\n  }\n\n  .ama-bsafe-substance-main {\n    grid-column: 1 \/ -1;\n    grid-row: 2;\n    min-width: 0;\n    width: 100%;\n  }\n}\n\n@media (max-width: 640px) {\n  .ama-bsafe-panel {\n    border-radius: 22px;\n  }\n\n  .ama-bsafe-inner {\n    padding: 24px 14px;\n  }\n\n  .ama-bsafe-title {\n    font-size: clamp(28px, 8.4vw, 36px);\n    letter-spacing: -0.035em;\n  }\n\n  .ama-bsafe-summary-strip {\n    display: grid;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-summary-item {\n    border-radius: 16px;\n  }\n\n  .ama-bsafe-accordion {\n    gap: 10px;\n  }\n\n  .ama-bsafe-item {\n    border-radius: 20px;\n  }\n\n  .ama-bsafe-item summary {\n    min-height: 60px;\n    padding: 12px 52px 12px 15px;\n  }\n\n  .ama-bsafe-item summary::after {\n    right: 14px;\n    width: 32px;\n    height: 32px;\n    font-size: 20px;\n  }\n\n  .ama-bsafe-item[open] summary::after {\n    font-size: 22px;\n  }\n\n  .ama-bsafe-acc-title {\n    font-size: 15px;\n    line-height: 1.18;\n    letter-spacing: -0.014em;\n  }\n\n  .ama-bsafe-acc-sub {\n    font-size: 12.2px;\n    line-height: 1.22;\n  }\n\n  .ama-bsafe-content {\n    padding: 20px 15px;\n  }\n\n  .ama-bsafe-content h2 {\n    font-size: clamp(24px, 7vw, 30px);\n  }\n\n  .ama-bsafe-grid {\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-card {\n    padding: 20px;\n  }\n\n  .ama-bsafe-substance-row {\n    padding: 16px;\n    grid-template-columns: 1fr;\n  }\n\n  .ama-bsafe-substance-code {\n    width: fit-content;\n    min-width: 0;\n    max-width: 100%;\n  }\n\n  .ama-bsafe-substance-threshold {\n    grid-column: 1;\n    grid-row: auto;\n  }\n\n  .ama-bsafe-validation {\n    padding: 20px;\n    border-radius: 20px;\n  }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6T2 drogues festives\"\u003e\n  \u003cdiv class=\"ama-bsafe-panel\"\u003e\n    \u003cdiv class=\"ama-bsafe-inner\"\u003e\n      \u003cheader class=\"ama-bsafe-header\"\u003e\n              \u003cspan class=\"ama-bsafe-kicker\"\u003eTest urinario droghe da festa senza cannabis\u003c\/span\u003e\n      \n              \u003ch2 class=\"ama-bsafe-title\"\u003e\n                Drugdiag® 6T2: test urinario ketamina, MDMA, 3-MMC, oppiacei, anfetamine e metamfetamine\n              \u003c\/h2\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                Il \u003cstrong\u003etest urinario Drugdiag® 6T2\u003c\/strong\u003e, sviluppato dal \u003cstrong\u003elaboratorio francese Toda Pharma\u003c\/strong\u003e, rileva le principali \u003cstrong\u003edroghe da festa\u003c\/strong\u003e, stimolanti, dissociativi e oppiacei più ricercati del momento, \u003cstrong\u003eescludendo il cannabis\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                Permette di rilevare in un unico gesto la \u003cstrong\u003eketamina (KET)\u003c\/strong\u003e, la \u003cstrong\u003eMDMA \/ ecstasy\u003c\/strong\u003e, gli \u003cstrong\u003eoppiacei (MOP)\u003c\/strong\u003e, la \u003cstrong\u003e3-MMC\u003c\/strong\u003e, le \u003cstrong\u003eanfetamine (AMP)\u003c\/strong\u003e e le \u003cstrong\u003emetamfetamine (MET)\u003c\/strong\u003e.\n              \u003c\/p\u003e\n      \n              \u003cp class=\"ama-bsafe-lead\"\u003e\n                Questo test urinario risponde alle esigenze di \u003cstrong\u003eprivati\u003c\/strong\u003e, \u003cstrong\u003eoperatori sanitari\u003c\/strong\u003e, \u003cstrong\u003estrutture di prevenzione\u003c\/strong\u003e, \u003cstrong\u003eaziende\u003c\/strong\u003e e \u003cstrong\u003eoperatori del mondo festivo\u003c\/strong\u003e che desiderano identificare rapidamente le principali famiglie di sostanze stimolanti, sintetiche, dissociative e oppiacee.\n              \u003c\/p\u003e\n      \n              \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003e6 famiglie rilevate senza cannabis\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eKET, MDMA, MOP, 3-MMC, AMP, MET\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003ePrevenzione, salute, serate e festival\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n      \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eRilevazione\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 droghe da festa\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eSostanze rilevate\u003c\/h2\u003e\n\n          \u003cp\u003e\n            Il Drugdiag® 6T2 rileva sei famiglie di sostanze particolarmente ricercate in contesti festivi, professionali, medici o di prevenzione, con un orientamento specifico escluso il cannabis.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eKET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eKetamina:\u003c\/strong\u003e ketamina, Special K, Ket, sostanza dissociativa che può alterare fortemente la vigilanza.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA, ecstasy, taz, tata, molly, sostanza stimolante ed empatogena.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOppiacei:\u003c\/strong\u003e morfina, eroina, oppio e composti correlati.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003e3-MMC\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCatinone di sintesi:\u003c\/strong\u003e 3-MMC, 3MMC, 3-M, sostanza stimolante spesso associata all’ambiente festivo.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetamine:\u003c\/strong\u003e speed, pep, anfetamine e stimolanti correlati.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n\n            \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n              \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n              \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetamfetamine:\u003c\/strong\u003e meth, crystal, crystal meth, ice e derivati correlati.\u003c\/div\u003e\n              \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n            \u003c\/div\u003e\n          \u003c\/div\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            Il Drugdiag® 6T2 è particolarmente adatto allo screening delle droghe da festa e degli stimolanti più frequentemente ricercati: ketamina, ecstasy, 3-MMC, speed, crystal meth e oppiacei. Non rileva il cannabis.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizzi\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePrevenzione, salute, festa\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003ePerché questo test è particolarmente utile oggi?\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eAmbiente festivo e policonsumo\u003c\/h3\u003e\n              \u003cp\u003e\n                In serata, festival, club o contesti di policonsumo, le sostanze in circolazione possono includere ketamina, MDMA, 3-MMC, anfetamine, metamfetamine e oppiacei. Questo test consente una lettura più ampia rispetto a uno screening limitato.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003ePrevenzione e comprensione del rischio\u003c\/h3\u003e\n              \u003cp\u003e\n                In caso di dubbio, comportamento insolito, malessere o sospetto di consumo, il Drugdiag® 6T2 aiuta a capire meglio a quale famiglia di sostanze si può essere esposti.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eProfessionisti della salute\u003c\/h3\u003e\n              \u003cp\u003e\n                Il test può aiutare a orientare una presa in carico, un monitoraggio o una richiesta di conferma biologica quando il contesto clinico lo richiede.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eStrutture per eventi e operatori sul campo\u003c\/h3\u003e\n              \u003cp\u003e\n                Può essere utile per strutture di prevenzione, organizzatori di eventi, associazioni, squadre di riduzione del rischio e operatori che si confrontano con sostanze poco identificate.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003ePunti di forza del Drugdiag® 6T2\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eScreening mirato:\u003c\/strong\u003e ricerca le principali droghe da festa, stimolanti e oppiacei senza includere la cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eAmpia copertura:\u003c\/strong\u003e ketamina, MDMA, oppiacei, 3-MMC, anfetamine e metamfetamine.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eLettura del rischio:\u003c\/strong\u003e aiuta a differenziare diverse famiglie di sostanze molto diverse.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eRisultato rapido:\u003c\/strong\u003e lettura visiva in pochi minuti secondo il foglio illustrativo del produttore.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eProduttore francese:\u003c\/strong\u003e dispositivo progettato dal laboratorio Toda Pharma, n°1 nel test diagnostico rapido.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eQualità professionale:\u003c\/strong\u003e marcatura CE, ambiente qualità ISO 13485 e tracciabilità dei lotti.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eStrumento di prevenzione:\u003c\/strong\u003e utile per privati, professionisti della salute, strutture per eventi e operatori sul campo.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cdiv class=\"ama-bsafe-alert\"\u003e\n            \u003ch3\u003ePerché queste sostanze preoccupano così tanto?\u003c\/h3\u003e\n            \u003cp\u003e\n              La ketamina, la MDMA, la 3-MMC, le anfetamine, le metamfetamine e gli oppiacei possono provocare effetti gravi: agitazione, iperstimolazione, allucinazioni, disorientamento, perdita di controllo, sedazione profonda, depressione respiratoria o malessere grave a seconda delle sostanze e delle combinazioni.\n            \u003c\/p\u003e\n            \u003cp\u003e\n              Un test rapido può orientare un sospetto, ma non sostituisce mai una presa in carico medica o un’analisi tossicologica di laboratorio quando il contesto lo richiede.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eRisultati\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eLettura e interpretazione\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eLettura e interpretazione\u003c\/h2\u003e\n\n          \u003cp\u003e\n            Il Drugdiag® 6T2 fornisce un risultato analitico preliminare. Permette di orientare rapidamente un sospetto di esposizione a determinate famiglie di droghe da festa, stimolanti, dissociativi o oppiacei.\n          \u003c\/p\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003eRisultato negativo\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un risultato negativo indica che le famiglie ricercate non sono state rilevate oltre le soglie del test. Ciò non garantisce l’assenza assoluta di qualsiasi sostanza, soprattutto se la molecola presente non fa parte del pannello ricercato.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eRisultato positivo\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un risultato positivo indica una reazione compatibile con la presenza di una famiglia ricercata: ketamina, MDMA, oppiacei, 3-MMC, anfetamine o metamfetamine. In contesti medici, professionali, ufficiali o contestati, è raccomandata una conferma in laboratorio.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eRisultato non valido\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Un risultato non valido può essere dovuto a una cattiva manipolazione, un volume insufficiente di campione o il mancato rispetto del tempo di lettura. È quindi necessario rifare un test con un nuovo dispositivo.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eNomi di strada associati alle famiglie ricercate\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eKET :\u003c\/strong\u003e ketamina, Special K, Ket.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMDMA :\u003c\/strong\u003e ecstasy, taz, tata, molly.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMOP :\u003c\/strong\u003e ero, eroina, oppio, morfina.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003e3-MMC :\u003c\/strong\u003e 3-MMC, 3MMC, 3-M.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eAMP :\u003c\/strong\u003e speed, pep, anfetamine.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eMET :\u003c\/strong\u003e meth, crystal, crystal meth, ice.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            I nomi di strada cambiano rapidamente e non garantiscono mai la composizione reale del prodotto consumato. Uno stesso nome può indicare sostanze diverse a seconda del lotto, della regione o del circuito di distribuzione.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eTecnica\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualità e affidabilità\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eCompetenza tecnica\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-bsafe-grid\"\u003e\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eTecnologia a oro colloidale\u003c\/h3\u003e\n              \u003cp\u003e\n                Il dispositivo utilizza l’immunocromatografia a competizione con anticorpi marcati con oro colloidale, permettendo una lettura chiara, rapida e adatta agli usi professionali.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eAffidabilità GC\/MS\u003c\/h3\u003e\n              \u003cp\u003e\n                La precisione di questo dispositivo professionale di screening urinario è stata confrontata con il metodo di riferimento in laboratorio, la cromatografia in fase gassosa accoppiata alla spettrometria di massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n\n            \u003carticle class=\"ama-bsafe-card\"\u003e\n              \u003ch3\u003eConformità qualità\u003c\/h3\u003e\n              \u003cp\u003e\n                Progettato dal laboratorio francese Toda Pharma, questo dispositivo medico di diagnosi \u003ci\u003ein vitro\u003c\/i\u003e è certificato \u003cstrong\u003eCE\u003c\/strong\u003e, con un sistema di qualità conforme alla norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e completa tracciabilità dei lotti.\n              \u003c\/p\u003e\n            \u003c\/article\u003e\n          \u003c\/div\u003e\n\n          \u003ch3\u003eCaratteristiche principali\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eTipo di test :\u003c\/strong\u003e test urinario orientato a droghe da festa, stimolanti, dissociativi e oppiacei.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFamiglie ricercate :\u003c\/strong\u003e KET, MDMA, MOP, 3-MMC, AMP, MET.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eParticolarità :\u003c\/strong\u003e pannello specifico senza cannabis.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e dispositivo urinario a lettura rapida.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenzione, salute, strutture festive, campo, aziende e auto-controllo responsabile.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eProduttore :\u003c\/strong\u003e laboratorio francese Toda Pharma, n°1 nel test di diagnosi rapida.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eQualità:\u003c\/strong\u003e dispositivo medico diagnostico in vitro con marcatura CE e ISO 13485.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003ch3\u003eAssenza di reazioni crociate\u003c\/h3\u003e\n\n          \u003cul class=\"ama-bsafe-list\"\u003e\n            \u003cli\u003e\n\u003cstrong\u003eFarmaci comuni:\u003c\/strong\u003e aspirina, ibuprofene, paracetamolo, amoxicillina, penicillina, destrometorfano.\u003c\/li\u003e\n            \u003cli\u003e\n\u003cstrong\u003eSostanze fisiologiche e alimentari:\u003c\/strong\u003e caffeina, colesterolo, emoglobina, creatinina, vitamina C, acido urico.\u003c\/li\u003e\n          \u003c\/ul\u003e\n\n          \u003cp class=\"ama-bsafe-note\"\u003e\n            Il test deve essere utilizzato conformemente alle istruzioni del produttore. In caso di risultato positivo, dubbio o contestato, è sempre raccomandata una conferma tramite analisi di laboratorio.\n          \u003c\/p\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n        \u003cdetails class=\"ama-bsafe-item\"\u003e\n          \u003csummary\u003e\n            \u003cspan\u003e\n              \u003cspan class=\"ama-bsafe-acc-title\"\u003eDomande frequenti\u003c\/span\u003e\n              \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDomande frequenti\u003c\/span\u003e\n            \u003c\/span\u003e\n          \u003c\/summary\u003e\n          \u003cdiv class=\"ama-bsafe-content\"\u003e\n            \u003ch2\u003eDomande frequenti\u003c\/h2\u003e\n\n          \u003cdiv class=\"ama-inner-accordion\"\u003e\n            \u003cdetails open\u003e\n              \u003csummary\u003eIl test rileva la ketamina?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sì. Il Drugdiag® 6T2 rileva la \u003cstrong\u003eketamina (KET)\u003c\/strong\u003e con una soglia di \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eIl test rileva la 3-MMC?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sì. Rileva specificamente la \u003cstrong\u003e3-MMC\u003c\/strong\u003e con una soglia di rilevamento di \u003cstrong\u003e1000 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eIl test rileva l’ecstasy?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sì. Rileva la \u003cstrong\u003eMDMA\u003c\/strong\u003e, spesso chiamata \u003cstrong\u003eecstasy\u003c\/strong\u003e, \u003cstrong\u003etaz\u003c\/strong\u003e o \u003cstrong\u003emolly\u003c\/strong\u003e, con una soglia di \u003cstrong\u003e500 ng\/mL\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eIl test rileva speed e crystal meth?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Sì. Rileva le \u003cstrong\u003eanfetamine (AMP)\u003c\/strong\u003e e le \u003cstrong\u003emetamfetamine (MET)\u003c\/strong\u003e, corrispondenti in particolare alle denominazioni \u003cstrong\u003espeed\u003c\/strong\u003e, \u003cstrong\u003emeth\u003c\/strong\u003e, \u003cstrong\u003ecrystal meth\u003c\/strong\u003e o \u003cstrong\u003eice\u003c\/strong\u003e.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003ePerché questo test non include la cannabis?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  Perché è progettato per rilevare specificamente altre famiglie di sostanze: ketamina, ecstasy, oppiacei, 3-MMC, anfetamine e metamfetamine. È quindi pertinente quando la necessità riguarda droghe da festa diverse dalla cannabis.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n\n            \u003cdetails\u003e\n              \u003csummary\u003eUn risultato positivo ha valore definitivo?\u003c\/summary\u003e\n              \u003cdiv class=\"ama-accordion-content\"\u003e\n                \u003cp\u003e\n                  No. Un test rapido fornisce un risultato analitico preliminare. In ogni contesto ufficiale, medico, giudiziario, amministrativo, disciplinare o contestato, è necessaria una conferma mediante metodo analitico di laboratorio.\n                \u003c\/p\u003e\n              \u003c\/div\u003e\n            \u003c\/details\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-cta\"\u003e\n            \u003cp\u003eHai bisogno di un consiglio o di un preventivo per un ordine professionale?\u003c\/p\u003e\n            \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n              Richiedi un preventivo\n            \u003c\/a\u003e\n          \u003c\/div\u003e\n\n          \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n            \u003cp\u003e\n              \u003cstrong\u003eAvvertenze legali :\u003c\/strong\u003e Questo dispositivo medico diagnostico \u003ci\u003ein vitro\u003c\/i\u003e è destinato a un uso preventivo, professionale o personale responsabile. Fornisce un risultato analitico preliminare e non sostituisce un’analisi tossicologica di laboratorio. In caso di risultato positivo, dubbio, contestato o in situazioni ufficiali, mediche, giudiziarie, amministrative o disciplinari, è raccomandata una conferma mediante metodo analitico di laboratorio.\n            \u003c\/p\u003e\n          \u003c\/div\u003e\n          \u003c\/div\u003e\n        \u003c\/details\u003e\n\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unità","offer_id":56426436034884,"sku":null,"price":19.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 5","offer_id":56426436067652,"sku":null,"price":94.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 10","offer_id":56426436100420,"sku":null,"price":179.0,"currency_code":"USD","in_stock":true},{"title":"Confezione da 25","offer_id":56426436133188,"sku":null,"price":399.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_NPS.png?v=1777893890","url":"https:\/\/ama-prevention.com\/it\/products\/test-urinario-drugdiag-6t2-nuove-droghe-di-sintesi","provider":"AMA Prévention ","version":"1.0","type":"link"}